Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and …

BM Wei, LP Fox, BH Kaffenberger, AM Korman… - Journal of the American …, 2024 - Elsevier
Drug-induced hypersensitivity syndrome (DiHS), also known as drug reaction with
eosinophilia and systemic symptoms (DRESS), is a severe cutaneous adverse reaction …

Pulmonary manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review

PT Taweesedt, CW Nordstrom… - BioMed Research …, 2019 - Wiley Online Library
Background. The syndrome of drug reaction with eosinophilia and systemic symptoms
(DRESS) is a rare, yet potentially fatal hypersensitivity reaction, most commonly associated …

Drug-induced hypersensitivity syndrome (DIHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): clinical features and pathogenesis

N Hama, R Abe, A Gibson, EJ Phillips - The Journal of Allergy and Clinical …, 2022 - Elsevier
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic
symptoms (DIHS/DRESS) is one example of a severe delayed T-cell–mediated adverse …

Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome

AR Cardones - Clinics in Dermatology, 2020 - Elsevier
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a severe
cutaneous drug reaction characterized by fever, lymphadenopathy, hematologic …

Drug reaction with eosinophilia and systemic symptoms (DRESS): focus on the pathophysiological and diagnostic role of viruses

GA Ramirez, M Ripa, S Burastero, G Benanti… - Microorganisms, 2023 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a heterogeneous,
multiorgan and potentially life-threatening drug-hypersensitivity reaction (DHR) that occurs …

Less known gastrointestinal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review of the literature

D Jevtic, I Dumic, T Nordin, A Singh, N Sulovic… - Journal of Clinical …, 2021 - mdpi.com
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a potentially
life threatening severe cutaneous drug reaction. Most patients develop eosinophilia, a rash …

Immunopharmacogenomics: mechanisms of HLA‐associated drug reactions

P Deshpande, RJ Hertzman… - Clinical …, 2021 - Wiley Online Library
The human leukocyte antigen (HLA) system is the most polymorphic in the human genome
that has been associated with protection and predisposition to a broad array of infectious …

Genomic risk factors driving immune-mediated delayed drug hypersensitivity reactions

Y Li, P Deshpande, RJ Hertzman, AM Palubinsky… - Frontiers in …, 2021 - frontiersin.org
Adverse drug reactions (ADRs) remain associated with significant mortality. Delayed
hypersensitivity reactions (DHRs) that occur greater than 6 h following drug administration …

The pharmacogenomic landscape of an Indigenous Australian population

SR Samarasinghe, W Hoy, S Jadhao… - Frontiers in …, 2023 - frontiersin.org
Background: Population genomic studies of individuals of Indigenous ancestry have been
extremely limited comprising< 0.5% of participants in international genetic databases and …

Exploring recent advances in drugs severe cutaneous adverse reactions immunopathology

R Cadot, P Gery, V Lenief, JF Nicolas, M Vocanson… - Allergy, 2025 - Wiley Online Library
Severe cutaneous adverse reactions to drugs (SCARs) are rare but life‐threatening delayed
allergies. While they primarily affect the skin, they can also affect internal organs …